Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Kim

Showing results (591-600 of 636) with videos related to

Pageof 64
Sort By:
Molecular Biology Reports|February 13, 2021
Role of p53 in transcriptional repression of SVCT2Eun Ho Kim, Dong-In Koh, Yea Seong Ryu, et al.
Cancer Immunology Research|January 30, 2024
The Immune Suppressor IGSF1 as a Potential Target for Cancer ImmunotherapyDong-In Koh, Minki Lee, Yoon Sun Park, et al.
Cancer Biology & Therapy|August 25, 2023
Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancerYoon Sun Park, Joseph Kim, Yea Seong Ryu, et al.
Annals of Surgical Oncology|February 10, 2015
Maintenance of certification: what everyone needs to knowGlenda G Callender, Brian J Kaplan, Richard L White, et al.
Molecular Oncology|May 28, 2025
Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancerHannah G McDonald, Anna M Reagan, Charles J Bailey, et al.
Cancers|June 10, 2023
Creation of EGD-Derived Gastric Cancer Organoids to Predict Treatment ResponsesHannah G McDonald, Megan M Harper, Kristen Hill, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 12, 2025
Efficacy, Mechanisms and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients: A Randomized, Double-Blind, Placebo-Controlled TrialVikas S Sridhar, Luxcia Kugathasan, Yuliya Lytvyn, et al.
Cancer Medicine|August 29, 2025
Proto-Oncogene HRAS Transcript Level and Overall Survival in Stages II and III Colorectal CancerDonghyun Kim, Saima Sharif, Juan Antonio Raygoza Garay, et al.
Molecular Therapy Oncolytics|January 6, 2017
Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100Matthew P Morrow, Kimberly A Kraynyak, Albert J Sylvester, et al.
Future Oncology (London, England)|March 24, 2016
Current role of selective internal radiation with yttrium-90 in liver tumorsWan Yee Lau, Yee Leong Teoh, Khin Maung Win, et al.
Pageof 64

Showing results (591-600 of 636) with videos related to

Sort By:
Pageof 64
Molecular Biology Reports|February 13, 2021
Role of p53 in transcriptional repression of SVCT2Eun Ho Kim, Dong-In Koh, Yea Seong Ryu, et al.
Cancer Immunology Research|January 30, 2024
The Immune Suppressor IGSF1 as a Potential Target for Cancer ImmunotherapyDong-In Koh, Minki Lee, Yoon Sun Park, et al.
Cancer Biology & Therapy|August 25, 2023
Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancerYoon Sun Park, Joseph Kim, Yea Seong Ryu, et al.
Annals of Surgical Oncology|February 10, 2015
Maintenance of certification: what everyone needs to knowGlenda G Callender, Brian J Kaplan, Richard L White, et al.
Molecular Oncology|May 28, 2025
Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancerHannah G McDonald, Anna M Reagan, Charles J Bailey, et al.
Cancers|June 10, 2023
Creation of EGD-Derived Gastric Cancer Organoids to Predict Treatment ResponsesHannah G McDonald, Megan M Harper, Kristen Hill, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 12, 2025
Efficacy, Mechanisms and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients: A Randomized, Double-Blind, Placebo-Controlled TrialVikas S Sridhar, Luxcia Kugathasan, Yuliya Lytvyn, et al.
Cancer Medicine|August 29, 2025
Proto-Oncogene HRAS Transcript Level and Overall Survival in Stages II and III Colorectal CancerDonghyun Kim, Saima Sharif, Juan Antonio Raygoza Garay, et al.
Molecular Therapy Oncolytics|January 6, 2017
Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100Matthew P Morrow, Kimberly A Kraynyak, Albert J Sylvester, et al.
Future Oncology (London, England)|March 24, 2016
Current role of selective internal radiation with yttrium-90 in liver tumorsWan Yee Lau, Yee Leong Teoh, Khin Maung Win, et al.
Pageof 64